Ngernsombat, C. et al. 2026. Candesartan cilexetil as a repurposed therapeutic candidate for nasopharyngeal carcinoma: Integrated in vitro and in silico analyses. EXCLI Journal. 25, (Jan. 2026), 204–221. DOI:https://doi.org/10.17179/excli2025-9094.